vascular access Articles
-
Amplifi Vein Dilation System: A novel device under development designed to prepare veins for AVF creation
The Amplifi Vein Dilation System (Artio Medical) is is an innovative device designed to dilate arm veins in preparation for AVF surgery using rapid, non-pulsatile venous blood flow. Surendra Shenoy, M.D. (a vascular surgeon with specialist interest in vascular access and transplantation at Washington University School of Medicine, St Louis, Missouri, USA) describes the system as one of the most ...
-
Why auditing catheter dislodgement is a patient safety must
Chris Cheney at HealthLeaders Media released an article related to IV Catheter Dislodgement, the potential impact, and the need to audit these types of occurrences. The article focuses on Nancy Moureau’s work in understanding the impact of IV dislodgement, and ultimately a call to action: Records should be tracked with IV dislodgement reports as a mandatory effort, to continue to quantify ...
-
AngioDynamics and Cardiva Expand Partnership to Bring Life-Saving Products to More Patients in Europe
We are pleased to announce an expanded partnership with Cardiva, a Spanish-based medical device company. The partnership builds on an existing collaboration between AngioDynamics and Cardiva, which has seen the successful distribution of AngioDynamics’ vascular access portfolio in Spain and Portugal since 2012. The expanded partnership will now include AngioDynamics’ oncology ...
-
IV safety valve dev Linear Health wins GCMI accelerator grant – Via MassDevice
Linear Health Sciences was featured in MassDevice focused on the GCMI/LHS Partnership Medical device accelerator the Global Center for Medical Innovation has issued its 1st grant to Linear Health Sciences, developer of the Orchid safety release valve designed to prevent dislodgment of IVs. The Oklahoma City-based company said it is developing safety release valves for a variety of medical ...
-
Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access
Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. In a prospective phase II trial from 2012 to 2014 (NCT01744418), HAVs were implanted into 40 haemodialysis patients at three sites in ...
-
Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes
Background: Arteriovenous fistulae are the currently recommended gold standard vascular access modality for haemodialysis because of their prolonged patency, improved durability, and low risk of infection for those that mature. However, notable disadvantages are observed in terms of protracted maturation time, associated high rates of catheter use, and substantial abandonment rates. The aim of ...
-
New Medtech Accelerator Launches to Help Grow Southeast’s Presence in the Industry
A new kind of focused accelerator has joined the Atlanta startup scene. The Global Center for Medical Innovation (GCMI), a comprehensive medical device innovation center, is launching a new medtech accelerator. In partnership with medtech company Becton, Dickinson and Company, the accelerator will be a significant addition to the city’s growing medtech industry, especially with nearby ...
-
Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage
Keywords Vascular access · Hemodialysis · Healthcare costs · Health economics · Arteriovenous fistula · Arteriovenous graft Abstract Introduction: Hemodialysis (HD) in end-stage renal disease (ESRD) patients requires vascular access (VA) through an arteriovenous fistula (AVF), a prosthetic arteriovenous graft (AVG), or a central venous catheter. While AVF or ...
-
Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection
Background: Synthetic expanded polytetrafluorethylene (ePTFE) grafts are routinely used for vascular repair and reconstruction but prone to sustained bacterial infections. Investigational bioengineered human acellular vessels (HAVs) have shown clinical success and may confer lower susceptibility to infection. Here we directly compared the susceptibility of ePTFE grafts and HAV to bacterial ...
-
Chocolate PTCA Balloon Catheter for pre-dilatation of an occluded circumflex and second obtuse marginal arteries - Case Study
Incomplete stent expansion and malapposed stent struts are a predictor of subacute and late stent thrombosis. Appropriate lesion preparation prior to stent implantation is necessary to assure complete stent expansion and stent strut apposition. This is of particular importance in challenging lesions, in particular those with calcific plaque. The goal of the pre-dilatation is to obtain optimal ...
-
Chocolate PTCA Balloon Catheter for pre-dilatation of an occluded right coronary artery - Case Study
Incomplete stent expansion and malapposed stent struts are a predictor of subacute and late stent thrombosis. Appropriate lesion preparation prior to stent implantation is necessary to assure complete stent expansion and stent strut apposition. This is of particular importance in challenging lesions, in particular those with calcific plaque. The goal of the pre-dilatation is to obtain optimal ...
-
Remote Oncology Care: Review of Current Technology and Future Directions
Abstract Cancer patients frequently develop tumor and treatment-related complications, leading to diminished quality of life, shortened survival, and overutilization of emergency department and hospital services. Outpatient oncology treatment has potential to leave cancer patients unmonitored for long periods while at risk of clinical deterioration which has been exaggerated during the COVID19 ...
By Oncodisc
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you